HCV polymerase inhibitors

The invention provides compounds of the formula: (I) wherein B is a nucleobase selected from the groups (a) to (d) and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects. 本发明提供式：(I)的化合物，其中B为选自基团(a)至(d...

Full description

Saved in:
Bibliographic Details
Main Authors TORSSELL STAFFAN, WAHLING HORST, KALAYANOV GENADIY
Format Patent
LanguageChinese
English
Published 19.10.2018
Subjects
CHEMISTRY
DERIVATIVES THEREOF
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
SUGARS
Online AccessGet full text

Cover

More Information
Summary:The invention provides compounds of the formula: (I) wherein B is a nucleobase selected from the groups (a) to (d) and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects. 本发明提供式：(I)的化合物，其中B为选自基团(a)至(d)的核碱基，并且其他变量在权利要求中定义，其用于治疗或预防丙型肝炎病毒感染，以及相关的方面。
Bibliography:Application Number: CN201810472644